secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001477932-23-008068
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab CFO Wei Li Leong resigns effective Oct 30, 2023
-----------------------------------------------------------------

- Wei Li Leong resigned as CFO effective October 30, 2023; will stay for one additional month.
- Resignation not due to any disagreement with the company, management, or board.
- Company to actively identify a replacement CFO; no successor named as of Nov 3, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793223008068/0001477932-23-008068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793223008068/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-008068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer